BEAM
Price
$27.55
Change
-$2.34 (-7.83%)
Updated
Oct 22, 11:39 AM (EDT)
Capitalization
3.02B
19 days until earnings call
Intraday Buy/Sell Signals
LGND
Price
$186.66
Change
-$0.08 (-0.04%)
Updated
Oct 21 closing price
Capitalization
3.64B
14 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

BEAM vs LGND

Header iconBEAM vs LGND Comparison
Open Charts BEAM vs LGNDBanner chart's image
Beam Therapeutics
Price$27.55
Change-$2.34 (-7.83%)
Volume$8.57K
Capitalization3.02B
Ligand Pharmaceuticals
Price$186.66
Change-$0.08 (-0.04%)
Volume$135.41K
Capitalization3.64B
BEAM vs LGND Comparison Chart in %
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. LGND commentary
Oct 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and LGND is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 22, 2025
Stock price -- (BEAM: $29.89 vs. LGND: $186.66)
Brand notoriety: BEAM and LGND are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 127% vs. LGND: 75%
Market capitalization -- BEAM: $3.02B vs. LGND: $3.64B
BEAM [@Biotechnology] is valued at $3.02B. LGND’s [@Biotechnology] market capitalization is $3.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $109.29B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileLGND’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • LGND’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and LGND are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while LGND’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 4 bearish.
  • LGND’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than LGND.

Price Growth

BEAM (@Biotechnology) experienced а +17.58% price change this week, while LGND (@Biotechnology) price change was +3.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.36%. For the same industry, the average monthly price growth was +11.42%, and the average quarterly price growth was +63.20%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

LGND is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (-1.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LGND($3.64B) has a higher market cap than BEAM($3.02B). LGND YTD gains are higher at: 74.204 vs. BEAM (20.524). LGND has higher annual earnings (EBITDA): -45.94M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. LGND (255M). LGND has less debt than BEAM: LGND (5.74M) vs BEAM (155M). LGND has higher revenues than BEAM: LGND (188M) vs BEAM (60.3M).
BEAMLGNDBEAM / LGND
Capitalization3.02B3.64B83%
EBITDA-414.33M-45.94M902%
Gain YTD20.52474.20428%
P/E RatioN/A46.19-
Revenue60.3M188M32%
Total Cash1.15B255M451%
Total Debt155M5.74M2,699%
FUNDAMENTALS RATINGS
LGND: Fundamental Ratings
LGND
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
32
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMLGND
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
64%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
60%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 10 days ago
84%
Bearish Trend 13 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
63%
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PAVLX47.44N/A
N/A
T. Rowe Price Value Adv
PPSFX22.07N/A
N/A
Principal Large Cap Value III R3
USCGX14.76N/A
N/A
Victory Capital Growth
LVAGX17.27N/A
N/A
LSV Global Value Investor
ARSZX10.30N/A
N/A
AMG River Road Small-Mid Cap Value Z